HIVTransmission
Meeting category
Date(s)
9 Nov 2021 - 10 Nov 2021
Meeting type
Virtual Meeting

International Workshop on HIV Transmission 2021

Related Enduring Materials

Enduring Materials

Topics are subject to change. 

All times indicated in the program are in Eastern Standard Time (EST)Click here to convert the time into your time zone

Confirmed Speakers

Day 1 - Tuesday, 9 November 2021

Session 1: Current Trends in HIV Transmission in Real-World Settings - 09:05
09:05 AM EST
Emerging Trends on HIV Transmission in Africa
Christophe Fraser, PhD
PANGEA/ Big Data Institute, University of Oxford, United Kingdom
09:26 AM EST
Primary Infection, a Therapeutic Opportunity to Achieve Viral Remission
Asier Sáez-Cirión, PhD
Institut Pasteur, France
09:52 AM EST
Early Events in the Establishment of the HIV Reservoir in Acutely Infected Thai Adults - The RV254/SEARCH010 Study
Nicolas Chomont, PhD
Université de Montréal, Canada
10:14 AM EST
Dynamics of HIV-Specific Antibody Responses in Individuals Treated during Acute Infection
Dominic Paquin-Proulx, PhD
U.S. Military HIV Research Program (MHRP), United States
10:35 AM EST
Abstract-Driven Presentations
Kristin Wall
Associations between Schistosome Infection and Incident HIV Not Mediated by STIs or Vaginal Dysbioses in a Longitudinal Cohort of Zambian Women
#1 - Kristin Wall
Tali Wagner
Epidemiology and Transmission of Drug Resistance Mutations Among Treatment-Naïve People Living With HIV-1 in Israel, 2010-2018
#2 - Tali Wagner
Session 2: Long-Acting ARVs for Prevention - 11:30
11:30 AM EST
Long-Acting Lenacapavir for HIV Prevention
Moupali Das, MD, MPH
Gilead Sciences, United States
11:55 AM EST
Islatravir for HIV Prevention
Jay Grobler, PhD
Merck Research Laboratories, United States
12:14 PM EST
Abstract-Driven Presentations
Ivana Massud
Weekly Oral Tenofovir Alafenamide Protects Macaques From Vaginal and Rectal SHIV Infection
#4 - Ivana Massud
Michele Daly
Pharmacokinetics and Safety of Long-Acting Islatravir and Etonogestrel Implants in Macaques for HIV and Pregnancy Prevention
#5 - Michele Daly
Session 3: Vaccine Landscape - 13:30
13:30 PM EST
Self-Replicating RNA Vaccines
Robin Shattock, PhD
Imperial College London, United Kingdom
13:53 PM EST
RNA-Based Vaccines for HIV
Paolo Lusso, MD, PhD
National Institutes of Allergy and Infectious Diseases (NIAID), United States
14:16 PM EST
Therapeutic Vaccines
Christian Brander, PhD
IrsiCaixa, Spain
14:36 PM EST
eOD-GT8, the Recent Clinical Trial and Plans for Future Trials
William Schief, PhD
The Scripps Research Institute, United States

Day 2 - Wednesday, 10 November 2021

Session 4: Prevention by LA CAB - 09:00
09:00 AM EST
Characterization of HIV Infections in the Setting of CAB LA PrEP 
Susan Eshleman, MD, PhD
Johns Hopkins University School of Medicine, United States
09:19 AM EST
Longer-Acting Cabotegravir for HIV Prevention
Rahima Benhabbour, PhD, MSc
UNC, Chapel Hill, United States
09:51 AM EST
Abstract-Driven Presentations
Nikita Dukashe
Use of Undetectable Equals Untransmittable (U=U) Messaging as a Strategy to Bend the Curve of HIV Transmissions
#6 - Mandisa Nikita Dukashe
Session 5: New Challenges to HIV Transmission and Novel Prevention Strategies - 11:37
11:37 AM EST
STI Prevention by Doxycycline
Jean-Michel Molina, MD, PhD
Saint-Louis/Lariboisière Hospitals and University of Paris, France
11:59 AM EST
Point-of Care Adherence Testing for HIV Prevention and Treatment
Monica Gandhi, MD, MPH
University of California San Francisco, United States
11:18 AM EST
HIV in Persons Who Inject Drugs
Dita Broz, PhD, MPH
Centers for Disease Control and Prevention (CDC), United States
11:41 AM EST
Abstract-Driven Presentations
Claire Deleage
Origin and Characterization of SIV in Semen in Primary Infection of Rhesus Macaques
#7 - Claire Deleage
Richard Haaland
Pharmacology of Boosted and Unboosted Integrase Strand Transfer Inhibitors for Two Dose Event-Driven HIV Prevention Regimens Among Men Who Have Sex With Men
#8 - Richard Haaland
Amy Martin
Measurement of Doxycycline and Antiretroviral Drugs in Plasma and Mucosal Specimens for Preclinical and Clinical Evaluation of Multipurpose Prevention Strategies
#9 - Amy Martin
Session 6: Future of Monoclonal Antibodies - 12:50
12:50 PM EST
Next-Generation Broadly Neutralizing Monoclonals
Lucio Gama, PhD
NIAD/ NIH, Johns Hopkins School of Medicine, United States
13:14 PM EST
Engineering-Based Approaches to Improve bnAb Function
Joseph Jardine, PhD
IAVI - International AIDS Vaccine Initiative, United States
13:35 PM EST
Intravaginal Delivery of mRNA-Encoded Abs to Prevent Transmission of HIV
Philip Santangelo, PhD
Georgia Institute of Technology, United States
Overview
Welcome

Over the years, advances in HIV treatment have led to an enhanced understanding of the virus and improved care of patients living with HIV. However, our insights into the spread of the HIV virus remain limited. A more extensive exchange of knowledge on the various aspects of HIV transmission provides important outlooks for a better approach to the epidemic. For this purpose, an integrated forum was set up in 2006 to reveal the perspectives of experts from different fields, enabling discussion on all relevant mechanisms of HIV transmission. Since then the annual Transmission Workshops are valuable to those specialized (or specializing) in HIV transmission.

The main objective of this workshop is to provide a forum for basic scientists, clinicians, virologists, epidemiologists, and public health officials to present and to discuss the various aspects of the transmission of HIV. The ultimate goal of the workshop is the integration of efforts from all relevant disciplines in order to constrain the spread of (drug-resistant) HIV. We are sure that the workshop will help achieve this goal.

General Information 
COVID-19 Update
Responding to the changing COVID-19 situation, the International Workshop on HIV Transmission 2021 will be held as a virtual meeting on our interactive online platform.

We are available to answer any questions or concerns that you may have about your participation at the International Workshop on HIV Transmission 2021. For more information, please contact Christina Dammers at Christina.Dammers@amededu.com.

To stay updated on developments about the International Workshop on HIV Transmission 2021, make sure you are signed up for our newsletter.
Who Should Attend?
- Basic scientists
- Clinicians
- Virologists
- Epidemiologists
- Public health officials
- Microbiologists
Meeting Objectives
This workshop aims to:

- Enhance the integration of all relevant disciplines to constrain the spread of (drug-resistant) HIV; and

- Provide a forum to discuss the various aspects of the transmission of HIV.
Learning Objectives
After participating in this activity, participants will be able to:

- Be updated on the current trends in HIV transmission in real-world settings;
- Understand key challenges and opportunities in the development of antibody-mediated prevention of HIV transmission;
- Reflect on the pros and cons of the technologies currently employed to develop an HIV vaccine;
- Summarize clinical data supporting the use of the long-term formulations for HIV prevention;
- Increase understanding of upgraded long-term formulations for HIV prevention.

Practical Information 
Certificate of Attendance
A digital certificate of attendance will be sent to participants upon request by email, after they have successfully completed the workshop and post-meeting survey.
Language
The official language of the workshop is English. Translation will not be provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official workshop sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided that the speaker has given permission to do so.
Committees
Chairs 2021
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, they assist the Chairs by providing them with suggestions for speakers and topics. In addition, members of the Organizing Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Support
Silver Level Sponsor

Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals involved in HIV transmission.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Christina Dammers at christina.dammers@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company. *Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgment on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level.

Endorsers